Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder (2023)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; OSORIO, FLAVIA DE LIMA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; MORAIS, EDER ROBERTO DE - FMRP
- Unidade: FMRP
- DOI: 10.1192/j.eurpsy.2023.524
- Subjects: CANABINOIDES; TRANSTORNO OBSESSIVO-COMPULSIVO; SINTOMAS PSÍQUICOS; PSICOMETRIA
- Language: Inglês
- Imprenta:
- Source:
- Título: European Psychiatry
- ISSN: 0924-9338
- Volume/Número/Paginação/Ano: v. 66, suppl 1, p. S225-S226, abst. EPP0193, 2023
- Conference titles: European Congress of Psychiatry
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MORAIS , Eder Roberto de et al. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1192/j.eurpsy.2023.524. Acesso em: 06 maio 2026. , 2023 -
APA
Morais , E. R. de, Zuardi, A. W., Guimarães, F. S., Osório, F. de L., Hallak, J. E. C., Sanches, R. F., & J. A. S. Crippa,. (2023). Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder. European Psychiatry. Cambridge: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1192/j.eurpsy.2023.524 -
NLM
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2026 maio 06 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524 -
Vancouver
Morais ER de, Zuardi AW, Guimarães FS, Osório F de L, Hallak JEC, Sanches RF, J. A. S. Crippa. Open-label: the clinical effects of adding cannbidiol to usual care of patients with residual symptoms in the diagnosis of Obsessive Compulsive Disorder [Internet]. European Psychiatry. 2023 ; 66 S225-S226.[citado 2026 maio 06 ] Available from: https://doi.org/10.1192/j.eurpsy.2023.524 - Cannabinoids for the treatment of mental disorders [Carta]
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Impact of cognitive deficits in patients with cirrhosis and alcoholic hepatopathy after reduction in alcohol intake. [Carta]
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003249628.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
